Therapeutic strategies to overcome ALK resistance in cancer /

"Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops....

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Autres auteurs: Friboulet, Luc (Éditeur intellectuel)
Format: Électronique eBook
Langue:Inglés
Publié: London, United Kingdom : Academic Press, an imprint of Elsevier, [2021]
Collection:Cancer sensitizing agents for chemotherapy ; v. 13.
Sujets:
Lungs > Cancer > Treatment.
Anaplastic Lymphoma Kinase > antagonists & inhibitors
Lung Neoplasms > drug therapy
Antineoplastic Agents > pharmacology
Protein Kinase Inhibitors > therapeutic use
Poumons > Cancer > Traitement.
Lungs > Cancer > Treatment
Internet Resources.
Index not Present.
Accès en ligne:Texto completo

Internet

Texto completo

Error inesperado del formato de respuesta.
Informations d'exemplaires de

Documents similaires